<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE resolution PUBLIC "-//US Congress//DTDs/res.dtd//EN" "res.dtd">
<resolution public-private="public" resolution-stage="Introduced-in-Senate" resolution-type="senate-resolution" star-print="no-star-print" slc-id="S1-SEI23060-2NT-VY-HWK"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 SRES 270 IS: Designating July 15, 2023, as “National Leiomyosarcoma Awareness Day”.</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2023-06-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">III</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num>S. RES. 270</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action display="yes"><action-date date="20230622">June 22, 2023</action-date><action-desc><sponsor name-id="S284">Ms. Stabenow</sponsor> submitted the following resolution; which was referred to the <committee-name committee-id="SSJU00">Committee on the Judiciary</committee-name></action-desc></action><legis-type>RESOLUTION</legis-type><official-title display="yes">Designating July 15, 2023, as <quote>National Leiomyosarcoma Awareness Day</quote>.</official-title></form><preamble><whereas><text>Whereas leiomyosarcoma is a malignant sarcoma subtype, one of 70 to 100 such subtypes, that arises in smooth muscle and has several subtypes itself due to its vascularity and bone invasion; </text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas leiomyosarcoma is designated by the National Institutes of Health as a rare form of cancer;</text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas leiomyosarcoma is largely resistant to standard chemotherapy treatments, radiation treatments, and immunotherapy trials, with 40-year-old chemotherapy treatments still in use; </text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas leiomyosarcoma affects all age groups, including children, young adults, the middle-aged, and the elderly, and all genders;</text></whereas><whereas commented="no"><text>Whereas leiomyosarcoma is diagnosed in more than 2,000 individuals in the United States each year; </text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas, with respect to leiomyosarcoma, research and clinical trials remain complicated and extremely costly due to the difficulty of recruiting patients; </text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas survival and longevity for individuals with leiomyosarcoma has not significantly improved for at least 30 years;</text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas multidisciplinary care coordination teams, because of their expertise and experience, are critical to the health of leiomyosarcoma patients; </text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas researchers continue to strive to improve quality of life for leiomyosarcoma patients, improve outcomes in clinical trials, and promote enhanced survivorship; and</text></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas increased education and awareness about sarcoma and leiomyosarcoma will contribute to the well-being of the communities of the United States: Now, therefore, be it</text></whereas></preamble><resolution-body><section id="S1" display-inline="yes-display-inline" section-type="undesignated-section"><text>That the Senate—</text><paragraph id="id8e97bd1e3ee5486eb8c6511ce6b3b286"><enum>(1)</enum><text>designates July 15, 2023, as <quote>National Leiomyosarcoma Awareness Day</quote>;</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="idd11204bcd2d6400e8495cba5cc1833b3"><enum>(2)</enum><text>recognizes the challenges faced by leiomyosarcoma patients; and</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id827c11bf919c4bf8b925c55cc275160b"><enum>(3)</enum><text>commends the dedication of organizations, volunteers, researchers, and caregivers across the United States working to improve the quality of life of leiomyosarcoma patients and their families.</text></paragraph></section></resolution-body></resolution> 

